23-Gauge Vitrectomy with Brilliant Blue Assisted ILM Peeling in a High Myopic Macular Schisis

Show Description +

Joao Paulo Duprat, MD, shows an internal limiting membrane peeling inside a staphyloma of a high myopic eye with the diagnosis of a macular schisis. A tangential traction in the macular surface was likely caused by an epi-retinal membrane, or even the posterior hyaloid itself, clearly shown in the OCT. The peeling is assisted by brilliant blue dye and is performed during a 23 gauge vitrectomy. Two different forceps are used. ILM forceps allows a better initial separation of the ILM from the underneath retinal tissue. De Juan forceps have a greater grabbing capacity allowing the ILM to be pulled with a smaller tearing tendency. In the end of the surgery, in the moment of the first trocar, removal, a dense hemorrhage comes out by one of the sclerotomies, what is typical of a partial drainage of a choroidal hemorrhagic detachment.

Posted: 5/15/2012

23-Gauge Vitrectomy with Brilliant Blue Assisted ILM Peeling in a High Myopic Macular Schisis

Joao Paulo Duprat, MD, shows an internal limiting membrane peeling inside a staphyloma of a high myopic eye with the diagnosis of a macular schisis. A tangential traction in the macular surface was likely caused by an epi-retinal membrane, or even the posterior hyaloid itself, clearly shown in the OCT. The peeling is assisted by brilliant blue dye and is performed during a 23 gauge vitrectomy. Two different forceps are used. ILM forceps allows a better initial separation of the ILM from the underneath retinal tissue. De Juan forceps have a greater grabbing capacity allowing the ILM to be pulled with a smaller tearing tendency. In the end of the surgery, in the moment of the first trocar, removal, a dense hemorrhage comes out by one of the sclerotomies, what is typical of a partial drainage of a choroidal hemorrhagic detachment.

Posted: 5/15/2012

Please log in to leave a comment.

More in Retina

Observation vs. Vitrectomy for Floaters

Kyle Kovacs, MD; Matthew Starr, MD; and Neda Valikodath, MD

IL-6 Inhibition in Diabetic Macular Edema

Arshad M. Khanani, MD, MA, FASRS, and Roger A. Goldberg, MD

Phase 3 Clinical Trial Results for OTX-TKI

Patricio G. Schlottmann, MD

Using OCT and AI to Evaluate Uveitis

Parisa Emami-Naeini, MD, MPH